CORDIS · 316254 · FP7
BASTION From Basic to Translational Research in Oncology
Coordinator: WARSZAWSKI UNIWERSYTET MEDYCZNY (PL)
The BASTION project is envisioned to allow Medical University of Warsaw (MUW) to become a leading research and clinical oncology centre in Central Europe. Based on core ensemble of internationally recognized research groups and lead scientists BASTION aims to strengthen MUW’s research potential in basic and translational oncology via five operating objectives: (1) initiating and consolidating cooperation between 9 MUW research teams and 11 partnering organisations from leading European research labs and 2 innovation driven SMEs via secondments; (2) fostering exchange of scientific ideas and k…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
Co-funding: the European Union contributes €4.8M toward a total project budget of €5.3M — a funding rate of 89%, with the remainder covered by the consortium partners. The project runs over approximately 3.5 years from 2012-09-01 to 2016-02-29.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from PL
see all →- UASEEDs — SEEDS OF BRAVERY: supporting Ukraine’s tech start-up scene and bringing it closer to the EU101104445 · HORIZON · €20.0M
- P4Health — Centre of Excellence for Precise Phenotyping and BioDataBanking101136375 · HORIZON · €15.0M
- Astrocent Plus — Astrocent Plus -- Particle Astrophysics Science and Technology Centre101137080 · HORIZON · €15.0M
- TRIO-VI CoE — Translational Research and Innovation in Ophthalmology Vision - Centre of Excellence101136570 · HORIZON · €15.0M
- QuantERA III — QUANTERA III RIA: COFUND IN QUANTUM TECHNOLOGIES101212998 · HORIZON · €15.0M
- QuantERA II — QuantERA II ERA-NET Cofund in Quantum Technologies101017733 · H2020 · €15.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CSA-SA funding scheme.
- What is the EU contribution?
- The European Commission contributes €4.8M toward a total project budget of €5.3M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by WARSZAWSKI UNIWERSYTET MEDYCZNY (PL).
- What is the project timeline?
- The project runs from 2012-09-01 to 2016-02-29 — approximately 3.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 316254.